Literature DB >> 25832162

Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange.

Courtney Tate1, Peter Mollee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25832162     DOI： 10.5694/mja14.01125

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

1.  A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.

Authors:  Ryan Hunt; Ayla Yalamanoglu; James Tumlin; Tal Schiller; Jin Hyen Baek; Andrew Wu; Agnes B Fogo; Haichun Yang; Edward Wong; Peter Miller; Paul W Buehler; Chava Kimchi-Sarfaty
Journal:  Blood       Date:  2016-11-18       Impact factor: 22.113

2.  Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone.

Authors:  Melissa Nataatmadja; Dakshinamurthy Divi
Journal:  Clin Kidney J       Date:  2016-05-30

Review 3.  Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.

Authors:  Richard L Rauck
Journal:  Pain Pract       Date:  2019-02-28       Impact factor: 3.183
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.